AzTrials
AzTrials

Neurological RehabilitationNCT05662878

Evaluation of Hand Strength and Spasticity in Hemiplegic Patients

An observational study of Neurological Rehabilitation and Stroke, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim in this study is to evaluate spasticity and hand grip strength with a finger hand robot in the Turkish population. Read more about this study

Who is it for?
Ages 40 to 85 yearsHealthy volunteers can take part
What is being tested?
Assessment of Hand Strength and Spasticity
How many people
161 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2022to 30 Apr 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 250 hemiplegia patients and 50 healthy controls aged between 40-85 years who applied to our clinic will be included in the study.

Who may be able to join

  • Hemiplegic patients with sufficient cognitive and language skills to follow instructions will be included in the study.

Who cannot join

  • Uncooperative Patient
  • Having a skin ulcer on the hand,
  • Patients with contractures of the hand fingers will be excluded.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Afyonkarahisar Health Sciences University

    Afyonkarahisar, 03200

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of Hand Strength and Spasticity in Hemiplegic Patients Using Hand-Finger Robot Device

The aim in this study is to evaluate spasticity and hand grip strength with a finger hand robot in the Turkish population.

Read the detailed description

Spasticity has been defined as "irregular sensorimotor control resulting from upper motor neuron lesion manifesting as intermittent or sustained involuntary activation of muscles".

The commonly used tools in the evaluation of spasticity are subjective clinical scales, including Ashworth Scale (AS), Modified AS (MAS), Tardieu Scale (TS), Modified TS (MTS), and Tone Assessment Scale (TAS). Current scales are based on the clinician's perception of the patient assessing spasticity through their perceptions, experience, and training over the years. An objective measure of spasticity is required, and the development of robot-based systems for this purpose can help clinicians objectify their assessment.

It has been widely shown that robotic systems can be useful in the rehabilitation of adults and children with brain damage. In addition, these systems can be used to assess upper extremity function during treatment.

The aim in this study is to evaluate spasticity and hand grip strength with a finger hand robot in the Turkish population.

Being tested
Assessment of Hand Strength and Spasticity
Keywords
Hemiplegia, Spasticity, Hand Grip Strength, Finger-Hand Robot
Medical subject headings
Stroke, Hemiplegia, Muscle Spasticity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment of Hand Strength and SpasticityOther

    Assessment of Hand Strength and Spasticity

Study groups in NCT05662878
Study groupRoleWhat they receive
Patient GroupHemiplegic Patients
Receives: Other: Assessment of Hand Strength and Spasticity
Control GroupHealthy Individuals
Receives: Other: Assessment of Hand Strength and Spasticity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neurophysiological Evaluation

    Brunnstrom Staging is a test that evaluates the motor development of hemiplegic patients. In this test, the neurophysiological recovery process of the hemiplegic patient was defined as 6 stages. According to this staging, the lowest stage; stage 1 (flask, the stage without voluntary movement), the highest stage was determined as stage 6 (stage with isolated joint movement). In Brunnstrom staging, the hand, upper extremity, and lower extremity are evaluated separately.

    Measured: 2022.12-2023.1

  2. Muscle Power Assessment (MRC Scale)

    The MRC is a scale for muscle strength that ranges from 0 to 5, relative to the maximum expected for a given muscle.

    Measured: 2022.12-2023.1

  3. Spasticity Evaluation

    It was planned to evaluate spasticity with the Modified Ashworth Scale (MAS). In MAS, patients are evaluated over 4 points. 0; there is no increase in muscle tone, and 4 indicates that the extremity is rigid in flexion and extension.

    Measured: 2022.12-2023.1

  4. The Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    The Fugl-Meyer Assessment Scale was developed to quantitatively evaluate sensorimotor recovery after stroke. It is based on Brunnstrom motor recovery stages. Turkish validity and reliability study was conducted.

    Measured: 2022.12-2023.1

  5. Hand and Finger Grip Strength Assessment

    Grip strength will be evaluated with the Jamar hydraulic hand dynamometer. Patients will be asked to squeeze with maximum force and each measurement will be made three times, and their averages will be recorded in kg. Finger grip strength will be evaluated with the "Jamar Digital Pinchmeter". Patients will be placed in the sitting position with the wrist in 90° flexion and the forearm in the neutral position. Measurements will be made bilaterally in three different positions as lateral, palmar and fingertip grips. Patients will be asked to squeeze with maximum force and each measurement will be made three times, and their averages will be recorded in kg. The dynamometer has a dual scale readout which displays isometric grip force from 0-90 kg. Higher scores means better grip strength.

    Measured: 2022.12-2023.1

  6. Assessment with Amadeo Device

    Amadeo (Tyromotion, Graz, Austria) is an end-effector device designed for the hand and is one of the very few options currently available on the commercial market. It is a device that is attached to the forearm with its groove-shaped structure and to the fingers with the support of magnets using bandages. The device performs flexion and extension movements of the fingers. It moves the fingers of the patients in the patterns defined in the software of the device. It provides training with passive, assistive and active movements that are ideal for use in all phases of neurological rehabilitation. It was planned to measure finger ROM, muscle strength and spasticity with Amadeo device.

    Measured: 2022.12-2023.1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2022
  2. Study start15 Oct 2022
  3. Primary completion20 Feb 2023
  4. Study completion30 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
161 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05662878
Sponsor's protocol ID
HemiHFR22
Status last verified
May 2023
First submitted
15 Dec 2022
Last updated
9 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • de-la-Torre R, Ona ED, Balaguer C, Jardon A. Robot-Aided Systems for Improving the Assessment of Upper Limb Spasticity: A Systematic Review. Sensors (Basel). 2020 Sep 14;20(18):5251. doi: 10.3390/s20185251.

    PubMed 32937973
  • Dehem S, Gilliaux M, Lejeune T, Detrembleur C, Galinski D, Sapin J, Vanderwegen M, Stoquart G. Assessment of upper limb spasticity in stroke patients using the robotic device REAplan. J Rehabil Med. 2017 Jul 7;49(7):565-571. doi: 10.2340/16501977-2248.

    PubMed 28664214
  • Luo Z, Lo WLA, Bian R, Wong S, Li L. Advanced quantitative estimation methods for spasticity: a literature review. J Int Med Res. 2020 Mar;48(3):300060519888425. doi: 10.1177/0300060519888425. Epub 2019 Dec 4.

    PubMed 31801402

Questions about this trial

What is this clinical trial studying?

An observational study of Neurological Rehabilitation and Stroke, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neurophysiological Evaluation (time frame: 2022.12-2023.1). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05662878, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in